A label belongs to a particular product.
Our editorial method starts with the exact claim and the source that can support it. Every article distinguishes what we found from what still needs confirmation.
Separate the product from the offer
An FDA-approved product label can establish that product’s ingredients and labeled uses. It cannot establish what a different provider will supply. We do not transfer Prometrium’s formulation, approval or evidence to an unnamed compounded capsule.
Keep the evidence in view
We use current official labels, regulator material, clinical organizations and primary research where relevant. Provider pages support statements about their advertised offers. We identify source types, link claims to references and record source-check dates. Commercial terms can change after a check.
Explain the commercial relationship
CoreAge receives first commercial placement because this publication participates in its promotional publishing network. Comparisons explain that order. We do not translate it into an efficacy score, a safety ranking or a guarantee that one service is best for an individual.
Avoid invented experience
Our articles report document research, not hands-on treatment tests or patient interviews. We name no fictional medical reviewers. When a claim is unverified or two pages differ, we say what is unresolved rather than choose the more attractive version.
Keep treatment decisions personal
These articles do not prescribe doses, write cycle calendars or replace the instructions for a dispensed medicine. Questions about eligibility, symptoms, interactions and changes belong with the prescriber or pharmacist. A publication date is not a promise of continuous monitoring.